PDC-E2, the hallmark antigen of PBC, induces anti-mitochondrial antibodies (AMA) that cross-react with Novosphingobium aromaticivorans, which are conditioned by the disruption of the intestinal barrier and the increase in permeability that occurs in inflammatory bowel diseases (32). This evidence concerns the gene DLAT and inflammatory bowel disease.